all report title image

DEPRESSION THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Depression Therapeutics Market, By Drug Type [Antidepressants (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), Serotonin Modulators, Tricyclic & Tetracyclic Antidepressants, and Atypical Antidepressants), Antipsychotics, Others], By Indication (Major Depressive Disorder (MDD), Bipolar Disorder, Dysthymic Disorder, Postpartum Depression, Seasonal Affective Disorder (SAD), Premenstrual Dysphoric Disorder (PMDD), Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In: 28 Apr, 2026
  • Code: CMI1307
  • Page number: 180
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Drug Launches
    • Epidemiology
    • Pipeline Analysis
    • Distribution Landscape
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Depression Therapeutics Market

    , By Drug Type, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
        • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
        • Serotonin Modulators
        • Tricyclic & Tetracyclic Antidepressants
        • Atypical Antidepressants
    • Antipsychotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
  5. Global Depression Therapeutics Market

    , By Indication, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Major Depressive Disorder (MDD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Bipolar Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Dysthymic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Postpartum Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Seasonal Affective Disorder (SAD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Premenstrual Dysphoric Disorder (PMDD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
  6. Global Depression Therapeutics Market

    , By Distribution Channel, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Depression Therapeutics Market

    , By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region,  2021 –2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Takeda Pharmaceutical Company Limited.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Allergan plc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • H. Lundbeck A/S
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alkermes
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Allergan
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biogen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sage Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Depression Therapeutics Market” – Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.